Desmopressin vs DHEA Peptide
Overview
Desmopressin and DHEA Peptide are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Desmopressin and DHEA Peptide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Desmopressin | DHEA Peptide | |
|---|---|---|
| Category | Hormonal | Hormonal |
| Regulatory status (US) | FDA approved | Research use only |
| Typical dosage | 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) | 25-50 mg |
| Frequency | Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia) | daily |
| Reported benefits | central diabetes insipidus management, primary nocturnal enuresis in children, nocturia due to nocturnal polyuria, perioperative hemostasis in mild hemophilia A, hemostasis in Type I von Willebrand disease, management of polyuria following head trauma or pituitary surgery | Hormone balance, energy, anti-aging |
| Reported side effects | hyponatremia (boxed warning), headache, facial flushing, nausea, abdominal cramps, fluid retention, hypotension, reflex tachycardia, hypertension, tachyphylaxis with repeated dosing, rare anaphylaxis | Possible acne, hormone fluctuations |
Key differences
Primary use. Desmopressin is categorised under Hormonal, while DHEA Peptide falls under Hormonal. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Desmopressin: FDA-approved. DHEA Peptide: not FDA-approved; treated as a research compound.
Dosing. Desmopressin is typically dosed at 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) (Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia)). DHEA Peptide is typically dosed at 25-50 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Desmopressin and DHEA Peptide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Desmopressin and DHEA Peptide?
- Desmopressin and DHEA Peptide are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status. Desmopressin is FDA-approved for one or more indications, whereas DHEA Peptide is not FDA-approved; generally classified as a research compound.
- What is Desmopressin used for?
- Synthetic ADH analog (DDAVP) FDA-approved for diabetes insipidus, nocturnal enuresis, and bleeding disorders.
- What is DHEA Peptide used for?
- Hormone precursor support.
- Can you take Desmopressin and DHEA Peptide together?
- Some users combine peptides within a single protocol, but stacking Desmopressin and DHEA Peptide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Desmopressin or DHEA Peptide FDA-approved?
- Desmopressin is FDA-approved for one or more indications. DHEA Peptide is not FDA-approved; generally classified as a research compound.
Read the full articles
- Desmopressin — full monograph: mechanism, research, dosing & references
- DHEA Peptide — full monograph: mechanism, research, dosing & references